Travere Therapeutics Inc (NASDAQ:TVTX)

20.92
Delayed Data
As of Mar 24
 +0.54 / +2.65%
Today’s Change
17.82
Today|||52-Week Range
30.35
-0.52%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Travere Therapeutics Inc have a median target of 36.50, with a high estimate of 52.00 and a low estimate of 17.00. The median estimate represents a +74.47% increase from the last price of 20.92.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Travere Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.28
Sales
$50.7M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -24.54%
 
 
 
 
 
 
Growthannually -1.37%
 
 
 
 
 
 

Sales

Growthquarterly -9.19%
 
 
 
 
 
 
Growthannually 13.60%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.